Hormone Clinic Marketing That Grows TRT and HRT Practices Without the Ad Account Risk

Direct promotion of TRT (testosterone replacement therapy), BHRT (bioidentical hormone replacement therapy), and prescription peptides by name in ad creative is restricted on both Meta and Google. The workaround is educational creative (mechanism content, founder POV from the medical director, symptom-agnostic angles) routed to a compliant landing page where the prescription conversation happens with licensed clinical staff. Meta's Personal Health policy bans "you"-framed condition language. Google's Healthcare and Medicines policy restricts prescription hormone promotion. The compliant funnel runs successfully every day; the funnel design just looks different from generic supplement or wellness funnels.

SEO and AEO (Answer Engine Optimization) are the primary growth channels for hormone clinics because paid social restrictions cap direct promotion. Symptom-language SEO ranks for high-volume research queries ("low testosterone symptoms," "perimenopause weight gain," "why am I always tired") that route traffic to clinical landing pages with quiz funnel intake. The same content layer ranks in ChatGPT Search, Perplexity, Claude, and Google AI Overview when buyers research hormone optimization. Paid Meta and Google are layered on top with educational creative and indirect funnel architecture, but SEO carries the primary load.

Most hormone clinics see their first booked consults within 30 to 45 days of campaign launch, slightly slower than higher-velocity wellness verticals because the buyer requires longer research before booking a $300+ per month commitment. Symptom-language SEO shows movement in 90 to 180 days because the keyword competition is high but rewarded with much larger traffic volumes than direct hormone clinic queries. By month 6 most hormone clinics have a stable cost per booked consult, a measurable membership conversion rate, and visibility into the long-cycle protocol attach math.

Pricing varies by clinic size, ad spend, telemedicine vs in-person model, and state footprint. Single-location hormone clinics typically run $3,000 to $7,000 monthly retainer plus comparable ad spend. Multi-state telemedicine hormone brands run larger budgets matched to broader state targeting and compounding pharmacy partner integration. Raging Agency offers performance-based plans (zero retainer, commission on tracked revenue) and hybrid plans (retainer plus commission). Final pricing is scoped on a Strategy Call.

Yes. Multi-state telemedicine hormone clinics require state-by-state compliance review covering state-specific telemedicine prescribing rules (some states require in-person visit before controlled substances), state scope-of-practice rules for NP, PA, and RN prescribing, CPOM rules in California (51% MD ownership) and New York (100% MD ownership), state compounding pharmacy rules under 503A and 503B, and state-specific advertising restrictions for medical and telehealth services. The compliance review happens during onboarding and updates whenever the clinic expands to a new state.

Peptide marketing is the tightest compliance category in hormone clinic marketing. Some peptides (BPC-157, TB-500, sermorelin, ipamorelin) are not currently FDA-approved for therapeutic use and cannot be promoted by name in paid ad creative without triggering Unapproved Substances enforcement on Google and Personal Health policy enforcement on Meta. FDA-approved peptide medications can be marketed in compliant frame with proper substantiation. Most hormone clinics offering peptides market the protocol category at the program level ("longevity peptide program," "weight management protocol") rather than naming specific peptides in ad creative, with the prescription conversation happening at the consult.